Sepsis occurs when the body goes overboard in its attempt to fight off an infection. Immune cells rush in, overreact and wreak havoc on tissues and organs, often resulting in organ failure and death.
Aug 13, 2019
0
74
DDR1 is a receptor tyrosine kinase (RTK)—a cell surface receptor—that regulates multiple functions including the maintenance of the normal structure of tissues, but which also contributes to pathological conditions including ...
Aug 9, 2019
0
3
Bone marrow contains biological factories, which pump out billions of new blood cells daily. The non-blood cells that maintain this production also have the potential to produce bone, fat and cartilage. This output all starts ...
Jul 31, 2019
0
47
The research group around Professor Thomas Brunner at the University of Konstanz discovers the role that the LRH-1 protein plays in the immune system—Inhibiting this protein could help treat inflammatory diseases
Jul 25, 2019
0
3
Now, a new Salk Institute study, published on July 24, 2019, in the journal Science Advances, shows that researchers could target these hard-to-treat cancers by pursuing drugs that keep a cellular "switch," called CREB, from ...
Jul 24, 2019
0
51
A new study published in Cell Reports found that a transcription factor called Slug serves as "command central" for determining breast stem cell health, regulating both stem cell activity and repair of DNA damage. The research ...
Jul 16, 2019
0
28
The Fast and the Furious movie franchise meets the Fast N' Loud television series to define an oncogene that drives 35% of prostate cancers.
Jun 26, 2019
0
1
New research by cell biologists at the University of Toronto provides significant new insight into the very first step stem cells go through to turn into the specialized cells that make up organs.
Jun 20, 2019
0
1
The survival and fitness of multicellular organisms is tightly associated with their capacity to renew their tissues. This is particularly important for tissues that are permanently exposed to and challenged by the external ...
Jun 4, 2019
0
422
A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent ...
May 27, 2019
0
269
